...for the month of January goes to...
[pause for effect] Janssen Pharmaceutica [rapturous applause for a talent that has long gone unrecognized].
Phil Dawdy's got a piece on a recent Lancet paper, where a study has "discovered" that antipsychotics don't actually work, when it comes to reducing aggression:
Atypical Nation: Placebo Beats Anti-Psychotics In Treating Aggression
There has been comment on this in NYT, although I haven't found anything in the British press, on the subject:
Drugs Offer No Benefit in Curbing Aggression, Study Finds
And it is in this piece that Janssen excels itself, as follows:
"...Janssen, a Johnson & Johnson subsidiary, said that Risperdal only promotes approved uses, which in this country include the treatment of irritability associated with autism in children..."
In light of the fact that the Arkansas AG appears keen to fuck Janssen royally over its promotion of off label uses, I felt that the only explanation for the Janssen comment in the NYT had to be a delightfully absurd sense of humour:
Anti-psychotic drug marketed improperly, AG lawsuit says
Whatever the motivation, it's damn funny.
Matt
Subscribe to:
Post Comments (Atom)
.jpg)
No comments:
Post a Comment